1. Home
  2. GLBS vs ITRM Comparison

GLBS vs ITRM Comparison

Compare GLBS & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Maritime Limited

GLBS

Globus Maritime Limited

HOLD

Current Price

$1.75

Market Cap

21.9M

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.46

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBS
ITRM
Founded
2006
2015
Country
Greece
Ireland
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
24.3M
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
GLBS
ITRM
Price
$1.75
$0.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$9.00
AVG Volume (30 Days)
278.3K
1.3M
Earning Date
11-28-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,444,000.00
$390,000.00
Revenue This Year
$16.13
N/A
Revenue Next Year
$20.15
$325.95
P/E Ratio
N/A
N/A
Revenue Growth
18.49
N/A
52 Week Low
$0.99
$0.36
52 Week High
$1.99
$3.02

Technical Indicators

Market Signals
Indicator
GLBS
ITRM
Relative Strength Index (RSI) 68.40 44.75
Support Level $1.72 $0.44
Resistance Level $1.99 $0.48
Average True Range (ATR) 0.14 0.04
MACD 0.05 0.01
Stochastic Oscillator 70.24 53.35

Price Performance

Historical Comparison
GLBS
ITRM

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: